Hi! I'm asking is there any method out for a large quantity of DNA size selection, something like with 96-well plate. The traditional way is to excise agaroase gel and do DNA purification, but it's too labor-intensive for hundreds of samples. I think it would be perfect to do size selection in a 96-well plate. But something like Sephadex seems not able to do such selection (e.g. 250-300bp). Any idea? Thanks!
Unconfigured Ad
Collapse
X
-
thanks. but that's not size selection like cutting a narrow band from the gel, but rather just DNA purification.Originally posted by Zaag View PostAmpure has a protocol for 96 and 384 well plates. Link to protocol (PDF):
http://www.beckmangenomics.com/docum...000387v001.pdf
Comment
-
-
You can use the ratio of AMPure beads to sample to select a specific size range without using a gel. Since the beads are in a PEG/salt solution, altering the ratio of beads/sample will solubilize different sizes of DNA fragments. For example, using 0.6X AMPure beads removes DNA <500bp and using 1.2X removes DNA <150bp. Using two different ratios of beads will allow you to select a certain size range of your library. Using a 0.6X ratio will cause binding of DNA fragments >500bp, but the smaller fragments will still remain in the supernatant. You can take that supernatant and add it to a higher concentration of AMPure beads and then take the DNA bound to the beads to get a size selection based on the ratios you used. With the 0.6X and 1.2X ratios, your library would range from 150-500bp. Altering the ratios by 0.1X steps will allow you to collect narrower size ranges. This type of size selection isn't extremely accurate so you should only use it if appropriate for your application. Be sure to test this out on some 100bp ladder or something similar since there is a little bit of lot-to-lot variation.
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
-
by GATTACATLove this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
-
Channel: Articles
07-01-2026, 11:43 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 10:26 AM
|
0 responses
13 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
26 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
16 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
33 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
Comment